Clinical trial
Evaluation of Vasopressin in the Vessels of Ovarian Neoplasms
NCT00160472 · United States Department of Defense, U.S. Fed · Completed
Key facts
| NCT number | NCT00160472 |
|---|---|
| Title | Evaluation of Vasopressin in the Vessels of Ovarian Neoplasms |
| Official title | Evaluation of Vasopressin and Vasopressin Receptor Expression in the Arteries and Veins of Ovarian Neoplasms |
| Lead sponsor | United States Department of Defense, U.S. Fed |
| Status | Completed |
| Study type | Interventional |
| Conditions | Ovarian Neoplasms |
| Intervention type | Procedure |
| Interventions | removal of ovarian vessels |
| Enrollment | 110 |
| Start date | Mar 1, 2004 |
| Primary completion | Jan 1, 2009 |
| Completion | Jan 1, 2009 |
| First posted | Sep 12, 2005 |
| Last update posted | Feb 26, 2010 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: